Key Executives
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Justin Adam Hanka | Co Founder, CEO & Director | 32.58k | -- | 1973 |
Mr. John M. Dinan | Chief Financial Officer | 48.42k | -- | 1957 |
Dr. Lahiru Russell Ph.D. | Chief Scientist | -- | -- | -- |
MindBio Therapeutics Corp.
- Sector:
- Healthcare
- Industry: Biotechnology
Description
MindBio Therapeutics Corp., together with its subsidiaries, operates as a clinical stage drug development company in Australasia. The company engages in researching, developing, and testing microdosing of psychedelic substances as a potential treatment for the management of various mental health conditions, such as depression, anxiety, chronic pain, cognitive impairment, post-traumatic stress disorder, panic disorder, and opiate addictions. It also establishes and executes research protocols through formal clinical trials that are facilitated via digital therapeutic platforms; and invests in research for developing treatments for depression, anxiety, PTSD and chronic pain. In addition, the company develops MB22001, which is in Phase 2 clinical trial, for the treatment of major depressive disorder, as well as existential distress, anxiety, and depression associated with advanced stage cancer; and wearable devices to collect biometric data in mental health patients taking psychedelic medicines. MindBio Therapeutics Corp. was incorporated in 2021 and is headquartered in Vancouver, Canada.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available